RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000002.xml
Aktuelle Dermatologie 2009; 35(1/02): 49-57
DOI: 10.1055/s-2008-1077740
DOI: 10.1055/s-2008-1077740
Fort- und Weiterbildung
© Georg Thieme Verlag KG Stuttgart · New York
Photodynamische Therapie
Photodynamic TherapyWeitere Informationen
Publikationsverlauf
Publikationsdatum:
29. Januar 2009 (online)

Dr. med. Julia Steinbauer
Literatur
- 1 Tappeiner H. Über die Wirkung fluoreszierender Stoffe auf Infusorien nach Versuchen von Raab. Münch Med Wochenschr. 1900; 1 5-7
- 2 Dougherty T J, Kaufman J E, Goldfarb A. Photoradiation Therapy for the Treatment of Malignant Tumors. Cancer Res. 1978; 38 2628-2635
- 3 Kennedy J C, Pottier R H, Pross D C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B. 1990; 6 143-148
- 4 Klein A, Babilas P, Karrer S, Landthaler M, Szeimies R M. Photodynamic Therapy in Dermatology – an Update 2008. J Dtsch Dermatol Ges. 2008; 6 839-846
- 5 Babilas P, Kohl E, Maisch T. et al . In vitro and in vivo comparison of two different light sources for topical photodynamic therapy. Br J Dermatol. 2006; 154 712-718
- 6 Babilas P, Knobler R, Hummel S. et al . Variable pulsed light is less painful than light-emitting diodes for topical photodynamic therapy of actinic keratosis: a prospective randomized controlled trial. Br J Dermatol. 2007; 157 111-117
- 7 Gold M H, Nestor M S. Current treatments of actinic keratosis. J Drugs Dermatol. 2006; 5 (2 Suppl) 17-25
- 8 Lehmann P. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br J Dermatol. 2007; 156 793-801
- 9 Freeman M, Vinciullo C, Francis D. et al . A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat. 2003; 14 99-106
- 10 Morton C, Campbell S, Gupta G. et al . Action Investigators. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol. 2006; 155 1029-1036
- 11 Wulf H C, Pavel S, Stender I. et al . Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Derm Venereol. 2006; 86 25-28
- 12 Perrett C M, McGregor J M, Warwick J. et al . Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. Br J Dermatol. 2007; 156 320-328
- 13 Rhodes L E, de Rie M, Enström Y. et al . Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol. 2004; 140 17-23
- 14 Szeimies R M, Ibbotson S, Murrel D F. et al .Randomised clinical trial of 5-aminolevulinata-photodynamic
therapy (MAL-PDT) versus simple excision surgery for superficial basal cell
carcinoma. Poster präsentiert auf der EADV-Konferenz, Wien, Mai 2007.
- 15 Rhodes L E, de Rie M A, Leifsdottir R. et al . Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs. surgery for nodular basal cell carcinoma. Arch Dermatol. 2007; 143 1131-1136
- 16 Telfer N R, Colver G B, Morton C A. Guidelines for the management of basal cell carcinoma. Br J Dermatol. 2008; 159 35-48
- 17 Salim A, Leman J A, McColl J H. et al . Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol. 2003; 148 539-543
- 18 Morton C, Horn M, Leman J. et al . Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. Arch Dermatol. 2006; 142 729-735
- 19 Calzavara-Pinton P G, Venturini M, Sala R. et al . Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma. Br J dermatol. 2008; 159 137-144
- 20 Mori M, Campolmi P, Mavilia L. et al . Topical photodynamic therapy for primary cutaneous B-cell lymphoma: a pilot study. J Am Acad Dermatol. 2006; 54 524-526
- 21 Hayami J, Okamoto H, Sugihara A. et al . Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid. J Dermatol. 2007; 34 320-327
- 22 Karrer S, Szeimies R M. Photodynamische Therapie nichtonkologischer Indikationen. Hautarzt. 2007; 58 585-596
- 23 Wiegell S R, Wulf H C. Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial. Br J Dermatol. 2006; 154 969-976
- 24 Stender I M, Na R, Fogh H. et al . Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial. Lancet. 2000; 355 963-966
- 25 Stefanaki I M, Georgiou S, Themelis G C. et al . In vivo fluorescence kinetics and photodynamic therapy in condylomata acuminata. Br J Dermatol. 2003; 149 972-976
- 26 Chen K, Chang B Z, Ju M. et al . Comparative study of photodynamic therapy vs CO2 laser vaporization in treatment of condylomata acuminata: a randomized clinical trial. Br J Dermatol. 2007; 156 516-520
- 27 Asilian A, Davami M. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial. Clin Exp Dermatol. 2006; 31 634-637
- 28 Touma D, Yaar M, Whitehead S. et al . A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol. 2004; 140 33-40
- 29 Christiansen K, Bjerring P, Troilius A. 5-ALA for photodynamic photorejuvenation--optimization of treatment regime based on normal-skin fluorescence measurements. Lasers Surg Med. 2007; 39 302-310
- 30 Hauschild A, Szeimies R M. EADV Konferenz 16. – 20. 5. 2007 in Wien: Studie zu neuartigem 5-ALA-Pflaster (PD P 506 A). J Dtsch Dermatol Ges. 2007; 5 815
Prof. Dr. med. Rolf-Markus Szeimies
Klinik und Poliklinik für
Dermatologie
Universitätsklinikum Regensburg
Franz-Josef-Strauss-Allee 11
93053 Regensburg
eMail: Rolf-Markus.Szeimies@klinik.uni-r.de